Related Experiment Video

Updated: Jun 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Controversies in the management of bacterial meningitis

Trenna Sutcliffe1

  • 1Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario.

Paediatrics & Child Health
|January 5, 2010
PubMed

Insights

Bacterial meningitis management remains unclear, with varied clinician practices regarding dexamethasone (steroid) use and fluid restriction. This review clarifies current evidence on these critical interventions for childhood meningitis.

Area of Science:

  • Pediatric Infectious Diseases
  • Critical Care Medicine
  • Clinical Practice Guidelines

Background:

  • Bacterial meningitis in children presents significant morbidity and mortality.
  • Current clinical practice lacks consensus on optimal management strategies, particularly concerning steroid use and fluid restriction.
  • A 1999 survey revealed inconsistent dexamethasone recommendations among pediatric infectious diseases specialists.

Purpose of the Study:

  • To review the evidence and typical case presentation of bacterial meningitis.
  • To discuss controversies and current understanding of dexamethasone use in pediatric bacterial meningitis.
  • To analyze fluid restriction and intravenous fluid therapy based on available clinical trials.

Main Methods:

  • Literature review of bacterial meningitis management.
  • Discussion of a typical case presentation.
  • Analysis of a single prospective randomized clinical trial on fluid therapy.

Main Results:

  • Inconsistent application of dexamethasone recommendations for *Haemophilus influenzae* type b and *Streptococcus pneumoniae* meningitis.
  • Limited evidence base for standardizing fluid restriction and intravenous fluid therapy in bacterial meningitis.

Conclusions:

  • Further research and clear guidelines are needed to standardize the management of bacterial meningitis in children.
  • Clinicians should be aware of the evolving evidence regarding dexamethasone and fluid management.
  • Optimizing treatment strategies is crucial to reduce the significant morbidity and mortality associated with childhood bacterial meningitis.
Keywords:
Bacterial meningitisDexamethasoneFluid managementMeningitis

More Related Videos

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...